• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组腺相关病毒生产的药理学

Pharmacology of Recombinant Adeno-associated Virus Production.

作者信息

Penaud-Budloo Magalie, François Achille, Clément Nathalie, Ayuso Eduard

机构信息

INSERM UMR1089, University of Nantes, Centre Hospitalier Universitaire, Nantes, France.

Powell Gene Therapy, Department of Pediatrics, University of Florida, Gainesville, FL, USA.

出版信息

Mol Ther Methods Clin Dev. 2018 Jan 8;8:166-180. doi: 10.1016/j.omtm.2018.01.002. eCollection 2018 Mar 16.

DOI:10.1016/j.omtm.2018.01.002
PMID:29687035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5908265/
Abstract

Recombinant adeno-associated viral (rAAV) vectors have been used in more than 150 clinical trials with a good safety profile and significant clinical benefit in many genetic diseases. In addition, due to their ability to infect non-dividing and dividing cells and to serve as efficient substrate for homologous recombination, rAAVs are being used as a tool for gene-editing approaches. However, manufacturing of these vectors at high quantities and fulfilling current good manufacturing practices (GMP) is still a challenge, and several technological platforms are competing for this niche. Herein, we will describe the most commonly used upstream methods to produce rAAVs, paying particular attention to the starting materials (input) used in each platform and which related impurities can be expected in final products (output). The most commonly found impurities in rAAV stocks include defective particles (i.e., AAV capsids that do contain the therapeutic gene or are not infectious), residual proteins from host cells and helper viruses (adenovirus, herpes simplex virus, or baculoviruses), and illegitimate DNA from plasmids, cells, or helper viruses that may be encapsidated into rAAV particles. Given the role that impurities may play in immunotoxicity, this article reviews the impurities inherently associated with each manufacturing platform.

摘要

重组腺相关病毒(rAAV)载体已在150多项临床试验中使用,具有良好的安全性,并且在许多遗传疾病中具有显著的临床益处。此外,由于其能够感染非分裂细胞和分裂细胞,并作为同源重组的有效底物,rAAV正被用作基因编辑方法的工具。然而,大量生产这些载体并符合现行良好生产规范(GMP)仍然是一个挑战,并且有几个技术平台正在争夺这一领域。在此,我们将描述生产rAAV最常用的上游方法,特别关注每个平台使用的起始材料(输入)以及最终产品(输出)中可能出现的相关杂质。rAAV库存中最常见的杂质包括缺陷颗粒(即不含治疗性基因或无感染性的AAV衣壳)、宿主细胞和辅助病毒(腺病毒、单纯疱疹病毒或杆状病毒)的残留蛋白,以及可能被包装到rAAV颗粒中的来自质粒、细胞或辅助病毒的非法DNA。鉴于杂质可能在免疫毒性中发挥的作用,本文综述了与每个生产平台固有相关的杂质。

相似文献

1
Pharmacology of Recombinant Adeno-associated Virus Production.重组腺相关病毒生产的药理学
Mol Ther Methods Clin Dev. 2018 Jan 8;8:166-180. doi: 10.1016/j.omtm.2018.01.002. eCollection 2018 Mar 16.
2
Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.2型重组腺相关病毒的复制和包装完全由表达Rep和Cap的1型单纯疱疹病毒扩增子支持。
J Virol. 1997 Nov;71(11):8780-9. doi: 10.1128/JVI.71.11.8780-8789.1997.
3
Herpes simplex virus clearance during purification of a recombinant adeno-associated virus serotype 1 vector.在重组1型腺相关病毒载体纯化过程中单纯疱疹病毒的清除
Hum Gene Ther Clin Dev. 2014 Dec;25(4):212-7. doi: 10.1089/humc.2014.060.
4
High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.利用表达AAV-2 Rep和Cap的重组I型单纯疱疹病毒载体进行高滴度重组腺相关病毒的生产。
Gene Ther. 1999 Jun;6(6):986-93. doi: 10.1038/sj.gt.3300937.
5
Homologous Recombination Offers Advantages over Transposition-Based Systems to Generate Recombinant Baculovirus for Adeno-Associated Viral Vector Production.同源重组为基于转座子的系统提供了优势,用于生成重组杆状病毒以用于腺相关病毒载体生产。
Biotechnol J. 2021 Jan;16(1):e2000014. doi: 10.1002/biot.202000014. Epub 2020 Nov 16.
6
Comparison of highly pure rAAV9 vector stocks produced in suspension by PEI transfection or HSV infection reveals striking quantitative and qualitative differences.通过PEI转染或HSV感染在悬浮培养中产生的高纯度rAAV9载体储备的比较揭示了显著的定量和定性差异。
Mol Ther Methods Clin Dev. 2021 Dec 25;24:154-170. doi: 10.1016/j.omtm.2021.12.006. eCollection 2022 Mar 10.
7
Adeno-associated viral vectors for gene transfer and gene therapy.用于基因转移和基因治疗的腺相关病毒载体。
Biol Chem. 1999 Jun;380(6):613-22. doi: 10.1515/BC.1999.078.
8
Novel tools for production and purification of recombinant adenoassociated virus vectors.用于生产和纯化重组腺相关病毒载体的新型工具。
Hum Gene Ther. 1998 Dec 10;9(18):2745-60. doi: 10.1089/hum.1998.9.18-2745.
9
Recent Advances in Therapeutics and Manufacturing Processes of Recombinant Adeno-Associated Virus for the Treatment of Lung Diseases.用于治疗肺部疾病的重组腺相关病毒的治疗学和制造工艺的最新进展
Curr Gene Ther. 2025;25(3):237-256. doi: 10.2174/0115665232294935240826061311.
10
Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2 (rAAV2) particle assembly using stable producer cell lines.利用稳定的生产细胞系鉴定一种用于重组腺相关病毒2型(rAAV2)颗粒组装的复制缺陷型单纯疱疹病毒。
J Gene Med. 2004 May;6(5):555-64. doi: 10.1002/jgm.542.

引用本文的文献

1
A clinician's guide to AAV production - How manufacturing platforms shape vector properties.腺相关病毒(AAV)生产的临床医生指南——制造平台如何塑造载体特性。
Med Genet. 2025 Jul 17;37(3):169-177. doi: 10.1515/medgen-2025-2024. eCollection 2025 Jul.
2
AAVone: A cost-effective, single-plasmid solution for efficient AAV production with reduced DNA impurities.AAVone:一种经济高效的单质粒解决方案,用于高效生产腺相关病毒(AAV),并减少DNA杂质。
Mol Ther Nucleic Acids. 2025 May 14;36(2):102563. doi: 10.1016/j.omtn.2025.102563. eCollection 2025 Jun 10.
3
Development of an AAV-RNAi strategy to silence the dominant variant GNAO1 c.607G>A linked to encephalopathy.

本文引用的文献

1
A Robust System for Production of Superabundant VP1 Recombinant AAV Vectors.一种用于高效生产VP1重组腺相关病毒载体的稳健系统。
Mol Ther Methods Clin Dev. 2017 Nov 7;7:146-156. doi: 10.1016/j.omtm.2017.11.002. eCollection 2017 Dec 15.
2
Thermal Stability as a Determinant of AAV Serotype Identity.热稳定性作为腺相关病毒血清型身份的决定因素。
Mol Ther Methods Clin Dev. 2017 Jul 24;6:171-182. doi: 10.1016/j.omtm.2017.07.003. eCollection 2017 Sep 15.
3
Strategies to optimize capsid protein expression and single-stranded DNA formation of adeno-associated virus in Saccharomyces cerevisiae.
开发一种腺相关病毒RNA干扰策略以沉默与脑病相关的显性变异体GNAO1 c.607G>A。
Gene Ther. 2025 Apr 14. doi: 10.1038/s41434-025-00532-x.
4
Chromatography in Downstream Processing of Recombinant Adeno-Associated Viruses: A Review of Current and Future Practises.重组腺相关病毒下游加工中的色谱法:当前及未来实践综述
Biotechnol Bioeng. 2025 May;122(5):1067-1086. doi: 10.1002/bit.28932. Epub 2025 Feb 4.
5
Size-exclusion chromatography as a multi-attribute method for process and product characterization of adeno-associated virus.尺寸排阻色谱法作为腺相关病毒工艺和产品表征的多属性方法。
Mol Ther Methods Clin Dev. 2024 Nov 19;32(4):101382. doi: 10.1016/j.omtm.2024.101382. eCollection 2024 Dec 12.
6
Expression of Viral DNA Polymerase in Synthetic Recombinant Adeno-Associated Virus Producer Cell Line Enhances Full Particle Productivity.病毒DNA聚合酶在合成重组腺相关病毒生产细胞系中的表达提高了完整颗粒的产量。
Biotechnol Bioeng. 2025 Feb;122(2):424-434. doi: 10.1002/bit.28885. Epub 2024 Nov 22.
7
Characterization of residual microRNAs in AAV vector batches produced in HEK293 mammalian cells and Sf9 insect cells.在HEK293哺乳动物细胞和Sf9昆虫细胞中生产的腺相关病毒(AAV)载体批次中残留微小RNA的表征。
Mol Ther Methods Clin Dev. 2024 Jul 25;32(3):101305. doi: 10.1016/j.omtm.2024.101305. eCollection 2024 Sep 12.
8
Therapeutic Application and Structural Features of Adeno-Associated Virus Vector.腺相关病毒载体的治疗应用及结构特征
Curr Issues Mol Biol. 2024 Aug 2;46(8):8464-8498. doi: 10.3390/cimb46080499.
9
Adeno-associated virus vector delivery to the brain: Technology advancements and clinical applications.腺相关病毒载体向脑内的递送:技术进展与临床应用
Adv Drug Deliv Rev. 2024 Aug;211:115363. doi: 10.1016/j.addr.2024.115363. Epub 2024 Jun 19.
10
Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions.2型神经纤维瘤病相关神经鞘瘤病的基因治疗:最新进展、挑战与未来方向
Oncol Ther. 2024 Jun;12(2):257-276. doi: 10.1007/s40487-024-00279-2. Epub 2024 May 17.
在酿酒酵母中优化腺相关病毒衣壳蛋白表达和单链DNA形成的策略。
J Appl Microbiol. 2017 Aug;123(2):414-428. doi: 10.1111/jam.13511. Epub 2017 Jul 13.
4
Product-Related Impurities in Clinical-Grade Recombinant AAV Vectors: Characterization and Risk Assessment.临床级重组腺相关病毒载体中的产品相关杂质:表征与风险评估
Biomedicines. 2014 Mar 3;2(1):80-97. doi: 10.3390/biomedicines2010080.
5
Accurate Identification and Quantification of DNA Species by Next-Generation Sequencing in Adeno-Associated Viral Vectors Produced in Insect Cells.通过下一代测序对昆虫细胞生产的腺相关病毒载体中的DNA种类进行准确鉴定和定量分析。
Hum Gene Ther Methods. 2017 Jun;28(3):148-162. doi: 10.1089/hgtb.2016.185. Epub 2017 Apr 21.
6
AAV-ID: A Rapid and Robust Assay for Batch-to-Batch Consistency Evaluation of AAV Preparations.AAV-ID:一种用于腺相关病毒制剂批次间一致性评估的快速且可靠的检测方法。
Mol Ther. 2017 Jun 7;25(6):1375-1386. doi: 10.1016/j.ymthe.2017.04.001. Epub 2017 Apr 17.
7
5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency.α-1抗胰蛋白酶缺乏症基因治疗后的5年表达及中性粒细胞缺陷修复
Mol Ther. 2017 Jun 7;25(6):1387-1394. doi: 10.1016/j.ymthe.2017.03.029. Epub 2017 Apr 10.
8
Generation of infectious recombinant Adeno-associated virus in Saccharomyces cerevisiae.在酿酒酵母中产生具有感染性的重组腺相关病毒。
PLoS One. 2017 Mar 29;12(3):e0173010. doi: 10.1371/journal.pone.0173010. eCollection 2017.
9
Manufacturing Clinical Grade Recombinant Adeno-Associated Virus Using Invertebrate Cell Lines.使用无脊椎动物细胞系生产临床级重组腺相关病毒
Hum Gene Ther. 2017 Apr;28(4):350-360. doi: 10.1089/hum.2017.042.
10
Manufacturing of recombinant adeno-associated viruses using mammalian expression platforms.使用哺乳动物表达平台生产重组腺相关病毒。
Biotechnol J. 2017 Mar;12(3). doi: 10.1002/biot.201600193. Epub 2017 Feb 8.